For the Inventor, By the Inventor

Enter assignee name

Rhone-Poulenc Rorer S.a.

USPTO Granted Patents = 247

Trademarks = 6

Forward Citations = 2,969

Loading Chart...

Loading Chart...

330 inventors (with patents filed for the assignee):

Jean-Dominique Bourzat (29 out of 51 patents)

Serge Mignani (24 out of 69 patents)

Alain Commercon (23 out of 40 patents)

4. Patrick Jimonet (17 out of 23 patents)

5. Franco Manfre (17 out of 19 patents)

6. Herve Bouchard (14 out of 28 patents)

7. Alain Commercedillaon (14 out of 15 patents)

8. Jean-Claude Aloup (13 out of 23 patents)

9. Marc Capet (12 out of 41 patents)

10. Dominique Damour (12 out of 19 patents)

11. Claude Guyon (12 out of 24 patents)

12. Patrick Leon (12 out of 24 patents)

13. Marie-Christine Dubroeucq (11 out of 27 patents)

14. Arielle Genevois-Borella (9 out of 25 patents)

15. Patrice Yeh (9 out of 37 patents)

Core Competencies:

Adenoviral Vectors

Pharmaceutical Compositions

Recombinant Proteins

Taxoids

Nucleic Acids

Transgenic Animals

Peptide Inhibitors

Microspheres

Gene Transfer

Farnesyl Transferase Inhibitors

Heterocyclic Compounds

Nanoparticles

247 patents: Sort by Forward Citations

1. 6312946 - Viable contaminant particle free adenoviruses, their prepartion and use (2001-11-06),

2. 6294377 - Adenoviral vectors of canine origin (2001-09-25),

3. 6291679 - Process for preparing benzoperhydroisoindole compounds (2001-09-18),

4. 6288075 - Thiazolo[5,4,3-ij]quinolines, preparation and medicines containing the same (2001-09-11),

5. 6287762 - Purification of a triple helix formation with an immobilized oligonucleotide (2001-09-11),

6. 6261807 - Method for preparing a recombinant adenovirus genome (2001-07-17),

7. 6239270 - Nucleic acids encoding human calcium sensor protein (2001-05-29),

8. 6235497 - Recombinant expression of the rat vesicular acetylcholine transporter (2001-05-22),

9. 6210879 - Method for diagnosing schizophrenia (2001-04-03),

10. 6207675 - Pyrrole derivatives, their preparation and pharmaceutical compositions containing them (2001-03-27),

11. 6200798 - Defective recombinant adenoviruses with inactivated IVa2 gene (2001-03-13),

12. 6197980 - 4-Acetoxy-2&agr;-benzoyloxy-5&bgr;,20-epoxy-1&bgr;,7&bgr;,10&bgr;-trihydroxy-9-oxo-11-taxen-13&agr;-yl(2R,3S)-3-t-butoxycarbonylamino-3-phenyl-2-hydroxypropionate trihydrate (2001-03-06),

13. 6194582 - Taxoids, their preparation and pharmaceutical compositions containing them (2001-02-27),

14. 6187746 - Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof (2001-02-13),

15. 6180362 - Peptides which inhibit ras protein activity, their preparation and use (2001-01-30),

Rhone-Poulenc Rorer S.A. is a global pharmaceutical company specializing in the research, development, manufacturing, and marketing of pharmaceutical and healthcare products. With a focus on innovation and quality, we strive to improve the health and well-being of people worldwide. Visit our website to learn more about our diverse portfolio of products and our commitment to excellence.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

247 Patents

#2 in Antony

#95 in France

#3,396 in the World

Rhone-Poulenc Rorer S.a.

Forward Citations = 2,969

330 inventors:

Jean-Dominique Bourzat (29 out of 51 patents)

Serge Mignani (24 out of 69 patents)

Alain Commercon (23 out of 40 patents)

4. Patrick Jimonet (17 out of 23 patents)

5. Franco Manfre (17 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…